*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
*ST Jingfeng: Announcement of Resolutions of the 31st Meeting of the Eighth Board of Directors
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
*ST Jingfeng: Announcement on Abnormal Fluctuations and Serious Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Announcement on changes in the company\'s directors and senior management
*ST Jingfeng: Independent Director Nominee\'s Statement and Commitment
*ST Jingfeng: Semi-Annual Report Board Resolution Announcement
*ST Jingfeng: Independent Director Candidate Statement and Commitment
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Morgan Stanley (China) Limited's interim report on entrusted management of Hunan Jingfeng Pharmaceutical Co., Ltd.'s 2016 public issuance of corporate bonds (first tranche) for qualified investors.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Legal opinion of the first bondholders' meeting of 2024 for 16 Jingfeng 01 of Hunan Jingfeng Pharmaceutical Co., Ltd. by Zhong Lun Law Firm in Beijing.
No Data
No Data